KMT2A and leukemia: Utilizing an MLL-AF9 AML Msi2 conditional knockout model, Michael Kharas’ group determined that Msi2 deficiency led to a significant delay in leukemia development, decrease in leukemic cell infiltration, and a significant decrease in LICs (CD11b + Kit +) [137].